Transcriptomic analysis of ROS1+ non-small cell lung cancer reveals an upregulation of nucleotide synthesis and cell adhesion pathways
Source
Frontiers in oncology - ISSN 2234-943X-14 (2024) p. 1-19
Profiling targeted therapy responses in ROS1+ non-small cell lung cancer using genomically engineered patient-derived cell lines
Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Department of Medical Genetics, 2024,308 p.
Methylation biomarkers for pleural mesothelioma : from epigenetic landscape analysis to diagnostic assay development
Source
Antwerpen, Universiteit Antwerpen, Faculteit Geneeskunde en Gezondheidswetenschappen, 2024,236 p.
Implementing CRISPR/Cas9 into the study of anticancer drug resistance
Source
Interdisciplinary cancer research-p. 1-18
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial
Source
Gynecologic oncology - ISSN 0090-8258-191 (2024) p. 275-286